Acerus is a Canadian pharmaceutical company focused on the development, manufacture, marketing, and distribution of innovative, branded products that improve the patient experience.
Our vision is for Acerus to become Canada’s premier, fully integrated pharmaceutical company by way of four strategic imperatives:
- Launch smart product development programs utilizing a novel nasal gel delivery platform.
- Expand the Canadian product portfolio via in-licensing or the acquisition of assets with good growth potential.
- Partner rights to proprietary assets destined for markets outside Canada.
- Acquire legacy assets to supplement our financial position.
Learn more about Acerus at aceruspharma.com.